Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
YB-101 in Graves' Disease
NCT07682896Phase 2Recruiting
- Sponsor
- Yarrow Bioscience
- Start
- Jun 2026
- Primary completion
- Dec 2027
- Countries
- 2
01
Overview
A Phase 2 trial of GenSci098 in Graves' disease, sponsored by Yarrow Bioscience. Started Jun 2026; status: recruiting.
02
Drugs
GenSci098
03
Conditions
Graves' disease
Beyond the preview
Go deeper on NCT07682896.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07682896.